Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 1

Interventions

Rituximab 129 Cyclophosphamide 122 Doxorubicin 62 Vincristine 61 venetoclax 58 Prednisone 57 ibrutinib 52 Specimen Handling 50 fludarabine 47 Lenalidomide 47 Biopsy 46 obinutuzumab 43 acalabrutinib 42 Etoposide 41 fludarabine phosphate 36 Magnetic Resonance Spectroscopy 36 Cytarabine 35 CT-P10 35 Dexamethasone 34 Methotrexate 29 Bendamustine Hydrochloride 27 pembrolizumab 26 Nivolumab 22 blinatumomab 21 zanubrutinib 20 prednylidene 19 Calcium Dobesilate 19 deltacortene 18 Radiotherapy 18 Melphalan 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × axatilimab × Lymphoid × Clear all

NCT05723055 2026-05-08

NAHL

University of Utah

Phase 2 Active not recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡